Medplus Health Services Limited Publishes Business Responsibility and Sustainability Report for FY 2025-26

Medplus Health Services Limited Publishes Business Responsibility and Sustainability Report for FY 2025-26​

Medplus Health Services Limited, a major player in India's retail pharmacy sector, has released its comprehensive Business Responsibility and Sustainability Report (BRSR) covering the Financial Year 2025-26. The report details the company’s operational scale, commitment to corporate governance, workforce welfare, and environmental stewardship.

The company, established on November 30, 2006, operates nationwide and maintains a significant retail footprint. Medplus Health Services Limited reports that it has 5714 locations across 14 states, with 5 plants operating nationally. The reported paid-up capital stands at 240.11 million.

Operational Scope and Business Activities​

Medplus serves end-use consumers by providing essential healthcare items, including prescription medicines, overthecounter drugs, vitamins, medical devices, and sanitizers. The company’s business activities focus primarily on two areas of the hospital and medical care sector: pharmaceutical products and medical and orthopedic goods. These operations contribute 1.90% to the entity's turnover.

The organization maintains strong internal governance structures, ensuring that its policies are designed for transparency and accountability across all operations. Medplus operates with a zero-tolerance stance against corruption and bribery, maintaining a robust AntiBribery Policy, which applies to KMPs, Employees, and Workers.

Workforce Details and Social Commitments​

As of the end of the financial year, Medplus Health Services Limited reported a total employee count of 27,686. The organization reports that 31.76% of its employees are female.

The company places significant emphasis on employee well-being and provides comprehensive support mechanisms. Medplus has established a Grievance Mechanism accessible to all internal stakeholders, as outlined in the Code of Business Conduct available on its corporate website. Additionally, Mediclaim coverage is provided for employees. The company maintains policies covering disciplinary action and leave, aiming to ensure the holistic welfare of its workforce.

Sustainability and Environmental Stewardship​

The BRSR highlights Medplus's commitment to environmental stewardship and waste management. The company ensures the safe disposal of hazardous materials through specialized third-party agencies. To reduce operational impact, they are actively encouraging the use of reusable packaging, such as plastic crates, in warehouses instead of cardboard boxes for processes within the supply chain.

Medplus has also conducted comprehensive assessments concerning stakeholder engagement and human rights due diligence. They maintain an internal assessment mechanism for their BR policies, which cover governance, ethical conduct, and compliance with applicable laws.

A key focus area is ensuring sustainable practices across the value chain. The company sources drugs directly from manufacturers or wholesalers to mitigate risks associated with counterfeiting, and its supply chain process ensures secure dispensing and availability of medicines at retail outlets.

Key Performance Indicators (KPIs)​

The report provides specific details regarding resource consumption and emissions intensity:


Regarding water management, the company's total volume of water withdrawal stands at 5,710.16 kilolitres, with 5,385.49 kilolitres being consumed, and the remainder being discharged to third parties. The reported water intensity per rupee of turnover is 0.07, while the PPP-adjusted figure is 1.44.

Stakeholder Responsiveness​

Medplus has implemented a structured stakeholder engagement strategy that encompasses customers, employees, suppliers, and communities. Communication channels are multi-faceted, including social media monitoring, website feedback forms, and regular corporate communications to employees. The company reports zero consumer complaints regarding unfair trade practices or advertising in the current year.

MEDPLUS Stock Price Movement​

Medplus Health Services Limited shares gained today, closing at ₹715.2 after rallying 3.50% in post-market trading. The stock reached a daily high of ₹722.9 and saw a traded volume of 982,408 shares.